US 11699503
Methods of identifying and treating patient populations amenable to cancer immunotherapy
granted A61KA61K2039/57A61K38/193
Quick answer
US patent 11699503 (Methods of identifying and treating patient populations amenable to cancer immunotherapy) held by The Regents of the University of California expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/57, A61K38/193, A61K39/395, A61K39/3955